Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical, Hematompoietic Progenitor-Cell Transplant
Final rept. 15 Apr 2007-14 Apr 2011
M D ANDERSON CANCER CENTER HOUSTON TX
Pagination or Media Count:
This is the final progress report for this grant application and describes our progress to date developing T cells with specificity for CD19.
- Medicine and Medical Research